Journal of Materials Chemistry B, Год журнала: 2025, Номер unknown
Опубликована: Янв. 1, 2025
An in situ cascade-activated nanoplatform integrating tumor-targeted delivery and synergistic ferroptosis-chemotherapy was developed.
Язык: Английский
Journal of Materials Chemistry B, Год журнала: 2025, Номер unknown
Опубликована: Янв. 1, 2025
An in situ cascade-activated nanoplatform integrating tumor-targeted delivery and synergistic ferroptosis-chemotherapy was developed.
Язык: Английский
Advanced Science, Год журнала: 2025, Номер unknown
Опубликована: Май 5, 2025
Abstract The rapid deterioration and progression of hepatocellular carcinoma (HCC) is intimately associated with copper ion overload, integrating the cuproptosis mechanism for treatment HCC presents a promising prospect. Nevertheless, cell death complexity renders efficient removal all cells insufficient solely relying on pathway. Herein, GSH‐responsive prodrug hybridization nanoassembly CA‐4S 2 @ES‐Cu exploited, which targets delivery ions to mitochondria via Elesclomol, contributing mitochondrial dysfunction evoking cuproptosis. Simultaneously, depletes GSH release CA‐4, disrupting microtubule function suppressing proliferation angiogenesis, realize dual attack against ion‐mediated metastasis HCC. Furthermore, both in mouse model synergistically elicit oxidative stress amplify effect activated immunogenetic initiate vigorous antitumor immune response cascade assault modality. Conclusively, multilevel synergistic penetrates limitations single therapy implements multidimensional targeted
Язык: Английский
Процитировано
1Journal of Materials Chemistry B, Год журнала: 2025, Номер unknown
Опубликована: Янв. 1, 2025
An in situ cascade-activated nanoplatform integrating tumor-targeted delivery and synergistic ferroptosis-chemotherapy was developed.
Язык: Английский
Процитировано
0